Cited by 2,412Herpesvirus Infections and TreatmentsCytomegalovirus and herpesvirus researchViral Infections and Immunology Research

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults

Open access

Oxman, M.N., Levin, M.J., Johnson, G.R., Schmader, K.E., Straus, S.E., Gelb, L.D., Arbeit, R.D., Simberkoff, M.S., Gershon, A.A., Davis, L.E., Weinberg, A., Boardman, K.D., Williams, H.M., Zhang, J. Hongyuan, Peduzzi, P.N., Beisel, C.E., Morrison, V.A., Guatelli, J.C., Brooks, P.A., Kauffman, C.A., Pachucki, C.T., Neuzil, K.M., Betts, R.F., Wright, P.F., Griffin, M.R., Brunell, P., Soto, N.E., Marques, A.R., Keay, S.K., Goodman, R.P., Cotton, D.J., Gnann, J.W., Loutit, J., Holodniy, M., Keitel, W.A., Crawford, G.E., Yeh, S.-S., Lobo, Z., Toney, J.F., Greenberg, R.N., Keller, P.M., Harbecke, R., Hayward, A.R., Irwin, M.R., Kyriakides, T.C., Chan, C.Y., Chan, I.S.F., Wang, W.W.B., Annunziato, P.W., Silber, J.L.·2005·New England Journal of Medicine

DOI 10.1056/nejmoa051016

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: The incidence and severity of herpes zoster and postherpetic neuralgia increase with age in association with a progressive decline in cell-mediated immunity to varicella-zoster virus (VZV). We tested the hypothesis that vaccination against VZV would decrease the incidence, severity, or both of herpes zoster and postherpetic neuralgia among older adults. METHODS: We enrolled 38,546 adults 60 years of age or older in a randomized, double-blind, placebo-controlled trial of an investigational live attenuated Oka/Merck VZV vaccine ("zoster vaccine"). Herpes zoster was diagnosed according to clinical and laboratory criteria. The pain and discomfort associated with herpes zoster were measured repeatedly for six months. The primary end point was the burden of illness due to herpes zoster, a measure affected by the incidence, severity, and duration of the associated pain and discomfort. The secondary end point was the incidence of postherpetic neuralgia. RESULTS: More than 95 percent of the subjects continued in the study to its completion, with a median of 3.12 years of surveillance for herpes zoster. A total of 957 confirmed cases of herpes zoster (315 among vaccine recipients and 642 among placebo recipients) and 107 cases of postherpetic neuralgia (27 among vaccine recipients and 80 among placebo recipients) were included in the efficacy analysis. The use of the zoster vaccine reduced the burden of illness due to herpes zoster by 61.1 percent (P<0.001), reduced the incidence of postherpetic neuralgia by 66.5 percent (P<0.001), and reduced the incidence of herpes zoster by 51.3 percent (P<0.001). Reactions at the injection site were more frequent among vaccine recipients but were generally mild. CONCLUSIONS: The zoster vaccine markedly reduced morbidity from herpes zoster and postherpetic neuralgia among older adults.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa051016

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A 12-Item Short-Form Health Survey: Construction of Scales and Preliminary Tests of Reliability and Validity
WARE, J. E., KOSINSKI, M., & KELLER, S. D. (1996) · Medical Care · doi:10.1097/00005650-199603000-00003 · Cited by 17,392
A sharper Bonferroni procedure for multiple tests of significance
HOCHBERG, Y. (1988) · Biometrika · doi:10.1093/biomet/75.4.800 · Cited by 4,829
Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases
Daut, R. L., Cleeland, C. S., & Flanery, R. C. (1983) · Pain · doi:10.1016/0304-3959(83)90143-4 · Cited by 1,562
The Nature of Herpes Zoster: A Long-Term Study and a New Hypothesis
Hope-Simpson, R. E. (1965) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576505800106 · Cited by 1,389
Comparative analysis of two rates
Miettinen, O. S., & Nurminen, M. M. (1985) · Statistics in Medicine · doi:10.1002/sim.4780040211 · Cited by 1,111
Population-Based Study of Herpes Zoster and Its Sequelae
Ragozzino, M. W., Melton, L. J., Kurland, L. T., CHU, C. P., & PERRY, H. O. (1982) · Medicine · doi:10.1097/00005792-198209000-00003 · Cited by 921
Herpes Zoster
Gnann, J. W., & Whitley, R. J. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp013211 · Cited by 781
Self-citation
Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire
Brazier, J. E., Jones, N., & Kind, P. (1993) · Quality of Life Research · doi:10.1007/bf00435221 · Cited by 707
Postherpetic Neuralgia — Pathogenesis, Treatment, and Prevention
Kost, R. G., & Straus, S. E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607043350107 · Cited by 641
Self-citation
The Incidence of Herpes Zoster
Donahue, J. G. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.1995.00430150071008 · Cited by 618

Flagged first, then by citations

Show all 40 references

Research works printed but not linked: 2

Hope-Simpson RE, 1965, Proc R Soc Med, 58, 9
Hope-Simpson RE, 1975, J R Coll Gen Pract, 25, 571

Sorted by citations

Items 301–400 of 1,001

Incidence and Clinical Characteristics of Herpes Zoster After Lung Transplantation
Manuel, O., Kumar, D., Singer, L. G., Cobos, I., & Humar, A. (2008) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2007.09.028 · Cited by 79
Clinical and psychosocial correlates of post‐herpetic neuralgia
Volpi, A., Gatti, A., Pica, F., Bellino, S., Marsella, L., & Sabato, A. F. (2008) · Journal of Medical Virology · doi:10.1002/jmv.21254 · Cited by 79
Varicella Zoster Virus (VZV) and Herpes Simplex Virus (HSV) in Solid Organ Transplant Patients
Zuckerman, R. A., & Limaye, A. P. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12003 · Cited by 79
Safety and Immunogenicity of Heat-Treated Zoster Vaccine (ZVHT) in Immunocompromised Adults
Mullane, K. M., Winston, D. J., Wertheim, M. S., Betts, R. F., Poretz, D. M., Camacho, L. H., Pergam, S. A., Mullane, M. R., Stek, J. E., Sterling, T. M., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit344 · Cited by 78
Self-citation
Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine Coadministered With Seasonal Influenza Vaccine in Adults Aged 50 Years or Older
Schwarz, T. F., Aggarwal, N., Moeckesch, B., Schenkenberger, I., Claeys, C., Douha, M., Godeaux, O., Grupping, K., Heineman, T. C., López‐Fauqued, M., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix481 · Cited by 78
Neuropathic Pain in the Elderly
Giovannini, S., Coraci, D., Brau, F., Galluzzo, V., Loreti, C., Caliandro, P., Padua, L., Maccauro, G., Biscotti, L., & Bernabei, R. (2021) · Diagnostics · doi:10.3390/diagnostics11040613 · Cited by 78
Herpes Zoster
Schmader, K. E. (2016) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2016.02.011 · Cited by 78
Self-citation
Characterization of the Host Immune Response in Human Ganglia after Herpes Zoster
Gowrishankar, K., Steain, M. C., Cunningham, A. L., Rodriguez, M. J., Blumbergs, P. C., Slobedman, B., & Abendroth, A. (2010) · Journal of Virology · doi:10.1128/jvi.01020-10 · Cited by 78
Risk and impact of herpes zoster on patients with diabetes: A population-based study, 2009–2014
Muñoz-Quiles, C., López‐Lacort, M., Ampudia‐Blasco, F. J., & Díez‐Domingo, J. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1368600 · Cited by 78
Zoster Vaccine (Zostavax®)
Sanford, M., & Keating, G. M. (2010) · Drugs & Aging · doi:10.2165/10489140-000000000-00000 · Cited by 77
The Spectrum of Neurological Manifestations of Varicella–Zoster Virus Reactivation
Kennedy, P. G. E. (2023) · Viruses · doi:10.3390/v15081663 · Cited by 77
Post-Herpetic Neuralgia in Older Adults
Christo, P. J., Hobelmann, G., & Maine, D. N. (2007) · Drugs & Aging · doi:10.2165/00002512-200724010-00001 · Cited by 77
Incidence of Herpes Zoster and Persistent Post-Zoster Pain in Adults With or Without Diabetes in the United States
Suaya, J. A., Chen, S., Li, Q., Burstin, S. J., & Levin, M. J. (2014) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofu049 · Cited by 77
Self-citation
Meeting the Challenges of Immunizing Adults
Bridges, C. B., Hurley, L. P., Williams, W. W., Ramakrishnan, A., Dean, A. K., & Groom, A. V. (2015) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2015.08.014 · Cited by 78
Prevalence of Ocular Manifestations and Visual Outcomes in Patients With Herpes Zoster Ophthalmicus
Szeto, S., Chan, T. C. Y., Wong, R. L. M., Ng, A. L. K., Li, E. Y., & Jhanji, V. (2016) · Cornea · doi:10.1097/ico.0000000000001046 · Cited by 76
Population-based incidence of herpes zoster after introduction of a publicly funded varicella vaccination program
Tanuseputro, P., Zagorski, B., Chan, K. J., & Kwong, J. C. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.09.024 · Cited by 76
Herpes zoster: Burden of disease in France
Chiappe, S. G., Sarazin, M., Turbelin, C., Lasserre, A., Pelat, C., Bonmarin, I., Chosidow, O., Blanchon, T., & Hanslik, T. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.09.074 · Cited by 76
Recurrence Rate of Herpes Zoster and Its Risk Factors: a Population-based Cohort Study
Kim, Y. J., Lee, C. N., Lee, M. S., Lee, J. H., Lee, J. Y., Han, K., & Park, Y. M. (2018) · Journal of Korean Medical Science · doi:10.3346/jkms.2019.34.e1 · Cited by 76
Immunogenicity generated by mRNA vaccine encoding VZV gE antigen is comparable to adjuvanted subunit vaccine and better than live attenuated vaccine in nonhuman primates
Monslow, M. A., Elbashir, S., Sullivan, N. L., Thiriot, D. S., Ahl, P., Smith, J., Miller, E., Cook, J., Cosmi, S., Thoryk, E., et al. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.06.062 · Cited by 75
Predictors of pain intensity and persistence in a prospective Italian cohort of patients with herpes zoster: relevance of smoking, trauma and antiviral therapy
the VZV Pain Study Group, Parruti, G., Tontodonati, M., Rebuzzi, C., Polilli, E., Sozio, F., Consorte, A., Agostinone, A., Masi, F. D., Congedo, G., et al. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-58 · Cited by 75
Disease Burden Due to Herpes Zoster among Population Aged ≥50 Years Old in China: A Community Based Retrospective Survey
Li, Y., An, Z., Yin, D., Liu, Y., Huang, Z., Xu, J., Ma, Y., Tu, Q., Li, Q., & Wang, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152660 · Cited by 75
A framework for the systematic consideration of ethics, equity, feasibility, and acceptability in vaccine program recommendations
Ismail, S. J., Hardy, K., Tunis, M. C., Young, K., Sicard, N., & Quach, C. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.05.051 · Cited by 81
Herpes zoster and COVID-19 infection: a coincidence or a causal relationship?
Algaadi, S. A. (2021) · Infection · doi:10.1007/s15010-021-01714-6 · Cited by 75
Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data
Goldman, G. S., & King, P. G. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.05.050 · Cited by 75
Varicella and Herpes Zoster in Madrid, based on the Sentinel General Practitioner Network: 1997–2004
Pérez‐Farinós, N., Ordobás, M., García‐Fernández, C., Comas, L. G., Llabrés, S. C., Rodero, I., Gutiérrez-Rodríguez, A., García-Gutiérrez, J., & Ramírez, R. (2007) · BMC Infectious Diseases · doi:10.1186/1471-2334-7-59 · Cited by 75
Wet cupping therapy for treatment of herpes zoster: a systematic review of randomized controlled trials.
Cao, H., Zhu, C., & Liu, J. (2010) · PubMed · Cited by 75
Developing a vaccination evaluation model to support evidence-based decision making on national immunization programs
Kimman, T. G., Boot, H. J., Berbers, G. A. M., VERMEERDEBONDT, P., de Wit, G. A., & DEMELKER, H. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.03.022 · Cited by 75
Cost of shingles: population based burden of disease analysis of herpes zoster and postherpetic neuralgia
Friesen, K. J., Chateau, D., Falk, J., Alessi‐Severini, S., & Bugden, S. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2185-3 · Cited by 74
Safety of zoster vaccine in adults from a large managed‐care cohort: a Vaccine Safety Datalink study
Tseng, H. F., Liu, A., Sy, L. S., Marcy, S. M., FIREMAN, B. H., Weintraub, E., Baggs, J. M., Weinmann, S. A., Baxter, R. P., Nordin, J. D., et al. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02474.x · Cited by 74
Cost-effectiveness of an Adjuvanted Recombinant Zoster Vaccine in older adults in the United States
Curran, D., Patterson, B. J., Varghese, L., Oorschot, D. V., Buck, P. O., Carrico, J., Hicks, K. A., Lee, B., & Yawn, B. P. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.07.005 · Cited by 74
Risk of herpes zoster among diabetics: a matched cohort study in a US insurance claim database before introduction of vaccination, 1997–2006
Guignard, A. P., Greenberg, M. E., Lu, C., Rosillon, D., & Vannappagari, V. X. (2014) · Infection · doi:10.1007/s15010-014-0645-x · Cited by 73
Vaccine Immunology
Siegrist, C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00002-x · Cited by 81
Efficacy, effectiveness, and safety of herpes zoster vaccine in the immunocompetent and immunocompromised subjects: A systematic review and network meta-analysis
Xia, Y., Zhang, X., Zhang, L., & Fu, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.978203 · Cited by 77
Immunization in the adult immunocompromised host
Löbermann, M., Boršo, D., Hilgendorf, I., Fritzsche, C., Zettl, U. K., & Reisinger, E. C. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.05.015 · Cited by 71
A real‐time PCR assay to identify and discriminate among wild‐type and vaccine strains of varicella‐zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses
Harbecke, R., Oxman, M. N., Arnold, B. A., Ip, C. C. Y., Johnson, G. R., Levin, M. J., Gelb, L. D., Schmader, K. E., Straus, S. E., Wang, H., et al. (2009) · Journal of Medical Virology · doi:10.1002/jmv.21506 · Cited by 73
Self-citation
T-cell immunity to human alphaherpesviruses
Ouwendijk, W. J. D., Laing, K. J., Verjans, G. M. G. M., & Koelle, D. M. (2013) · Current Opinion in Virology · doi:10.1016/j.coviro.2013.04.004 · Cited by 73
Post-herpetic neuralgia – a review of current management and future directions
Schutzer-Weissmann, J. M., & Farquhar-Smith, P. W. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1392508 · Cited by 73
Increasing incidence associated with herpes zoster infection in British Columbia, Canada
Marra, F., Chong, M., & Najafzadeh, M. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1898-z · Cited by 72
Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine
Grupping, K., Cámpora, L., Douha, M., Heineman, T. C., Klein, N. P., Lal, H., Peterson, J., Vastiau, I., & Oostvogels, L. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix482 · Cited by 72
Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults
Macartney, K. K., Heywood, A. E., & McIntyre, P. B. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001833.pub3 · Cited by 72
Guidelines for screening, prophylaxis and critical information prior to initiating anti-TNF-alpha treatment.
Nordgaard-Lassen, I., Dahlerup, J. F., Bélard, E., Gerstoft, J., Kjeldsen, J., Kragballe, K., Ravn, P., Sørensen, I. J., Theede, K., & Tjellesen, L. (2012) · PubMed · Cited by 71
Cellular and Humoral Responses to a Second Dose of Herpes Zoster Vaccine Administered 10 Years After the First Dose Among Older Adults
Levin, M. J., Schmader, K. E., Pang, L., Williams‐Diaz, A., Zerbe, G. O., Canniff, J. D., Johnson, M. J., Caldas, Y. A., Cho, A., Lang, N., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv480 · Cited by 71
Self-citation
Varicella and herpes zoster vaccine development: lessons learned
Warren‐Gash, C., Forbes, H. J., & Breuer, J. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2017.1394843 · Cited by 71
Complete-Genome Phylogenetic Approach to Varicella-Zoster Virus Evolution: Genetic Divergence and Evidence for Recombination
Norberg, P., Liljeqvist, J., Bergström, T. B., Sammons, S. R., Schmid, D. S., & Loparev, V. N. (2006) · Journal of Virology · doi:10.1128/jvi.00835-06 · Cited by 71
Herpes Zoster and Recurrent Herpes Zoster
Shiraki, K., Toyama, N., Daikoku, T., Yajima, M., & for the Miyazaki Dermatologist Society (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofx007 · Cited by 71
Severe complications of herpes zoster.
Volpi, A. (2007) · PubMed · Cited by 70
Immunosupportive therapies in aging
Fülöp, T., Larbi, A., Hirokawa, K., Mocchegiani, E., Lesourd, B., Castle, S., Wikby, A., Franceschi, C., & Pawelec, G. (2007) · Clinical Interventions in Aging · doi:10.2147/ciia.2007.2.1.33 · Cited by 71
Recommendations of the Advisory Committee on Immunization Practices for use of herpes zoster vaccines
Dooling, K. L., Guo, A., Patel, M., Lee, G. M., Moore, K. L., Belongia, E. A., & Harpaz, R. (2018) · American Journal of Transplantation · doi:10.1111/ajt.14683 · Cited by 69
Healthcare Costs of Acute and Chronic Pain Associated with a Diagnosis of Herpes Zoster
Dworkin, R. H., White, R. G., O'connor, A., Başer, O., & Hawkins, K. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01231.x · Cited by 69
Herpes Zoster and Postherpetic Neuralgia in Older Adults
Schmader, K. E. (2007) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2007.03.003 · Cited by 69
Self-citation
Safety, tolerability, and immunogenicity of zoster vaccine in subjects with a history of herpes zoster
Mills, R. E., Tyring, S. K., Levin, M. J., Parrino, J., Li, X., Coll, K. E., Stek, J. E., Schlienger, K., Chan, I. S. F., & Silber, J. L. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.04.003 · Cited by 69
Self-citation
The health and economic burden of chickenpox and herpes zoster in Belgium
Bilcke, J., Ogunjimi, B., Marais, C., Smet, F. D., Callens, M. G., Callaert, K., Kerschaver, E. V., Ramet, J., Damme, P. V., & Beutels, P. (2012) · Epidemiology and Infection · doi:10.1017/s0950268811002640 · Cited by 69
Measurement of Varicella‐Zoster Virus (VZV)–Specific Cell‐Mediated Immunity: Comparison between VZV Skin Test and Interferon‐γ Enzyme‐Linked Immunospot Assay
Sadaoka, K., Okamoto, S., Gomi, Y., Tanimoto, T., Ishikawa, T., Yoshikawa, T., Asano, Y., Yamanishi, K., & Mori, Y. (2008) · The Journal of Infectious Diseases · doi:10.1086/592219 · Cited by 69
A short history of vaccination
Plotkin, S. L., & Plotkin, S. A. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3611-1.50005-2 · Cited by 68
Risk of Herpes Zoster in Adults Immunized with Varicella Vaccine
Hambleton, S., Steinberg, S. P., LaRussa, P. S., Shapiro, E. D., & Gershon, A. A. (2008) · The Journal of Infectious Diseases · doi:10.1086/522131 · Cited by 68
Self-citation
Live zoster vaccination in an immunocompromised patient leading to death secondary to disseminated varicella zoster virus infection
Alexander, K. E., Tong, P. L., Macartney, K. K., Beresford, R., Sheppeard, V. K., & Gupta, M. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.05.078 · Cited by 68
Herpes Zoster and Post-Herpetic Neuralgia—Diagnosis, Treatment, and Vaccination Strategies
Lim, D. Z. J., Tey, H. L., Salada, B. M. A., Oon, J. E. L., Seah, E.-J. D., Chandran, N. S., & Pan, J. Y. (2024) · Pathogens · doi:10.3390/pathogens13070596 · Cited by 67
A critical appraisal of ‘Shingrix’, a novel herpes zoster subunit vaccine (HZ/Su or GSK1437173A) for varicella zoster virus
Bharucha, T., Ming, D. K. Y., & Breuer, J. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1317410 · Cited by 67
Herpes Zoster
O’Connor, K., & Paauw, D. S. (2013) · Medical Clinics of North America · doi:10.1016/j.mcna.2013.02.002 · Cited by 67
Aggregate health and economic burden of herpes zoster in the United States: illustrative example of a pain condition
Harvey, M. J., Prosser, L. A., Rose, A. M., Ortega‐Sanchez, I. R., & Harpaz, R. (2019) · Pain · doi:10.1097/j.pain.0000000000001718 · Cited by 68
Safety of vaccines used for routine immunization in the United States: An updated systematic review and meta-analysis
Gidengil, C. A., Goetz, M. B., Newberry, S. J., Maglione, M., Hall, O., Larkin, J., Motala, A., & Hempel, S. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.03.079 · Cited by 75
Impairments in Health Functioning and Sleep Quality in Older Adults with a History of Depression
Motivala, S. J., Levin, M. J., Oxman, M. N., & Irwin, M. R. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00819.x · Cited by 66
Self-citation
A 70-Year-Old Woman With Shingles
Whitley, R. J. (2009) · JAMA · doi:10.1001/jama.2009.822 · Cited by 66
Herpes Zoster Vaccination in SLE: A Pilot Study of Immunogenicity
Guthridge, J. M., Cogman, A. R., Merrill, J. T., Macwana, S., Bean, K. M., Powe, T., Roberts, V., James, J. A., & Chakravarty, E. F. (2013) · The Journal of Rheumatology · doi:10.3899/jrheum.130170 · Cited by 66
Incremental 1-Year Medical Resource Utilization and Costs for Patients with Herpes Zoster from a Set of US Health Plans
White, R. R., Lenhart, G. M., Singhal, P. K., Insinga, R. P., Itzler, R. F., Pellissier, J. M., & Segraves, A. (2009) · PharmacoEconomics · doi:10.2165/11317560-000000000-00000 · Cited by 66
Varicella Zoster Virus in the Nervous System
Gilden, D., Nagel, M. A., Cohrs, R. J., Mahalingam, R., & Baird, N. L. (2015) · F1000Research · doi:10.12688/f1000research.7153.1 · Cited by 66
Treatment of Herpes Zoster
Opstelten, W., Eekhof, J. A., Neven, A. K., & Verheij, T. J. (1950) · The Lancet · doi:10.1016/s0140-6736(50)90598-8 · Cited by 65
Gabapentin Extended-Release Tablets for the Treatment of Patients with Postherpetic Neuralgia
Wallace, M. S., Irving, G. A., & Cowles, V. E. (2010) · Clinical Drug Investigation · doi:10.2165/11539520-000000000-00000 · Cited by 65
Update on Oral Herpes Virus Infections
Balasubramaniam, R., Kuperstein, A. S., & Stoopler, E. T. (2014) · Dental Clinics of North America · doi:10.1016/j.cden.2013.12.001 · Cited by 65
Herpes Zoster Pain, Postherpetic Neuralgia, and Quality of Life in the Elderly
Pickering, G. P., & Leplège, A. (2010) · Pain Practice · doi:10.1111/j.1533-2500.2010.00432.x · Cited by 65
Recommended immunization schedules for adults: Clinical practice guidelines by the Escmid Vaccine Study Group (EVASG), European Geriatric Medicine Society (EUGMS) and the World Association for Infectious Diseases and Immunological Disorders (WAidid)
Esposito, S., Bonanni, P., Maggi, S., Tan, L., Ansaldi, F., Lopalco, P. L., Dagan, R., Michel, J., Damme, P. V., Gaillat, J., et al. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2016.1150396 · Cited by 70
Herpes zoster in psoriasis patients treated with tofacitinib
Winthrop, K. L., Lebwohl, M., Cohen, A. D., Weinberg, J. M., Tyring, S. K., Rottinghaus, S. T., Gupta, P. K., Ito, K., Tan, H., Kaur, M., et al. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2017.03.023 · Cited by 65
Bortezomib and the Increased Incidence of Herpes Zoster in Patients with Multiple Myeloma
Kim, S. J., Kım, K., Kim, B., Lee, H. J., Kim, H., Lee, N.-R., Nam, S.-H., Kwon, J. H., Kim, H. J., Sohn, S. K., et al. (2008) · Clinical Lymphoma & Myeloma · doi:10.3816/clm.2008.n.031 · Cited by 65
A fresh perspective from immunologists and vaccine researchers: Active vaccination strategies to prevent and reverse Alzheimer's disease
Agadjanyan, M. G., Petrovsky, N., & Ghochikyan, A. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.06.1884 · Cited by 65
Extensive CD4 and CD8 T Cell Cross-Reactivity between Alphaherpesviruses
Jing, L., Laing, K. J., Dong, L., Russell, R. M., Barlow, R. S., Haas, J., Ramchandani, M. S., Johnston, C., Buus, S., REDWOOD, A. J., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502366 · Cited by 64
Prevention of herpes zoster and its painful and debilitating complications
Johnson, R. W., McElhaney, J. E., Pedalino, B., & Levin, M. J. (2007) · International Journal of Infectious Diseases · doi:10.1016/s1201-9712(07)60021-6 · Cited by 63
Self-citation
The risk of herpes zoster during biological therapy for psoriasis and other inflammatory conditions
Adelzadeh, L., Jourabchi, N., & Wu, J. J. (2013) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12307 · Cited by 63
Defective T Memory Cell Differentiation after Varicella Zoster Vaccination in Older Individuals
Qi, Q., Cavanagh, M., Saux, S. L., Wagar, L. E., Mackey, S., Hu, J., Maecker, H. T., Swan, G. E., Davis, M. M., Dekker, C. L., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005892 · Cited by 62
A meta-analysis of stroke risk following herpes zoster infection
Marra, F., Ruckenstein, J., & Richardson, K. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2278-z · Cited by 63
A Cost-Effectiveness Analysis of Vaccination for Prevention of Herpes Zoster and Related Complications: Input for National Recommendations
Prosser, L. A., Harpaz, R., Rose, A. M., Gebremariam, A., Guo, A., Ortega‐Sanchez, I. R., Zhou, F., & Dooling, K. L. (2019) · Annals of Internal Medicine · doi:10.7326/m18-2347 · Cited by 63
Infections in Patients with Cancer
Nesher, L., & Rolston, K. V. I. (2017) · Holland‐Frei Cancer Medicine · doi:10.1002/9781119000822.hfcm140 · Cited by 62
Burden of herpes zoster in the UK: findings from the zoster quality of life (ZQOL) study
Gater, A., Abetz‐Webb, L., Carroll, S., Mannan, A., Serpell, M. G., & Johnson, R. W. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-402 · Cited by 62
Risk of herpes zoster in patients with systemic lupus erythematosus: a three-year follow-up study using a nationwide population-based cohort
Chen, H., Chen, Y., Chen, T., Lan, J., Lin, C., & Chen, D.-Y. (2011) · Clinics · doi:10.1590/s1807-59322011000700009 · Cited by 62
Varicella Zoster Virus Latency
Eshleman, E. M., Shahzad, A., & Cohrs, R. J. (2011) · Future Virology · doi:10.2217/fvl.10.90 · Cited by 62
The impact of varicella zoster virus: Chronic pain
Opstelten, W., McElhaney, J. E., Weinberger, B., Oaklander, A. L., & Johnson, R. W. (2010) · Journal of Clinical Virology · doi:10.1016/s1386-6532(10)70003-2 · Cited by 62
Quality of Life Impact of an Adjuvanted Recombinant Zoster Vaccine in Adults Aged 50 Years and Older
Curran, D., Oostvogels, L., Heineman, T. C., Matthews, S., McElhaney, J. E., McNeil, S., Díez‐Domingo, J., Lal, H., Andrews, C. P., Athan, E., et al. (2018) · The Journals of Gerontology Series A · doi:10.1093/gerona/gly150 · Cited by 62
Self-citation
A Double-Blind, Randomized, Controlled, Multicenter Safety and Immunogenicity Study of a Refrigerator-Stable Formulation of Zostavax
Gilderman, L. I., Lawless, J. F., Nolen, T. M., Sterling, T. M., Rutledge, R. Z., Fernsler, D. A., Azrolan, N., Sutradhar, S., Wang, W. W., Chan, I. S. F., et al. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00310-07 · Cited by 62
Self-citation
Variability in the immune system: of vaccine responses and immune states
Shen-Orr, S. S., & Furman, D. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.07.009 · Cited by 61
Prevention of varicella and zoster by live attenuated VZV vaccine
Hambleton, S. (2007) · Frontiers in bioscience · doi:10.2741/2876 · Cited by 61
Cost-effectiveness of the Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
Le, P., & Rothberg, M. B. (2018) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.7431 · Cited by 61
Do varicella vaccination programs change the epidemiology of herpes zoster? A comprehensive review, with focus on the United States
Harpaz, R. (2019) · Expert Review of Vaccines · doi:10.1080/14760584.2019.1646129 · Cited by 61
Vaccines for older adults
Cunningham, A. L., McIntyre, P. B., Subbarao, K., Booy, R., & Levin, M. J. (2021) · BMJ · doi:10.1136/bmj.n188 · Cited by 64
Self-citation
Herpes Zoster Ophthalmicus
Sanjay, S., Huang, P. K., & Lavanya, R. (2010) · Current Treatment Options in Neurology · doi:10.1007/s11940-010-0098-1 · Cited by 61
Disease burden of herpes zoster in Sweden - predominance in the elderly and in women - a register based study
Studahl, M., Petzold, M., & Cassel, T. N. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-586 · Cited by 61
Live Attenuated Varicella-Zoster Vaccine in Hematopoietic Stem Cell Transplantation Recipients
Issa, N. C., Marty, F. M., Leblebjian, H., Galar, A., Shea, M. M., Antin, J. H., Soiffer, R. J., & Baden, L. R. (2013) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2013.11.013 · Cited by 61
Is chickenpox so bad, what do we know about immunity to varicella zoster virus, and what does it tell us about the future?
Gershon, A. A. (2017) · Journal of Infection · doi:10.1016/s0163-4453(17)30188-3 · Cited by 65
Self-citation
Chemotherapy: oral side effects and dental interventions. A review of the literature
Poulopoulos, A. K., Papadopoulos, P., & Andreadis, D. (2017) · Stomatological Disease and Science · doi:10.20517/2573-0002.2017.03 · Cited by 63
Successful Vaccines
Amanna, I. J., & Slifka, M. K. (2018) · Current topics in microbiology and immunology · doi:10.1007/82_2018_102 · Cited by 68
New viral vaccines
Arvin, A. M., & Greenberg, H. B. (2005) · Virology · doi:10.1016/j.virol.2005.09.057 · Cited by 62
Status of prophylactic and therapeutic genital herpes vaccines
Awasthi, S., & Friedman, H. M. (2014) · Current Opinion in Virology · doi:10.1016/j.coviro.2014.02.006 · Cited by 60

Authors: Oxman, M. N., Levin, M. J., Johnson, G. R., Schmader, K. E., Straus, S. E., Gelb, L. D., Arbeit, R. D., Simberkoff, M. S., Gershon, A. A., Davis, L. E., Weinberg, A., Boardman, K. D., Williams, H. M., Zhang, J. H., Peduzzi, P. N., Beisel, C. E., Morrison, V. A., Guatelli, J. C., Brooks, P. A., Kauffman, C. A., Pachucki, C. T., Neuzil, K. M., Betts, R. F., Wright, P. F., Griffin, M. R., Brunell, P., Soto, N. E., Marques, A. R., Keay, S. K., Goodman, R. P., Cotton, D. J., Gnann, J. W., Loutit, J., Holodniy, M., Keitel, W. A., Crawford, G. E., Yeh, S.-S., Lobo, Z., Toney, J. F., Greenberg, R. N., Keller, P. M., Harbecke, R., Hayward, A. R., Irwin, M. R., Kyriakides, T. C., Chan, C. Y., Chan, I. S. F., Wang, W. W. B., Annunziato, P. W., & Silber, J. L.
Affiliations: University of California San Diego (US)
Durham VA Medical Center (US)
Duke Medical Center (US)
National Institutes of Health (US)
Washington University in St. Louis (US)
VA Boston Healthcare System (US)
VA NY Harbor Healthcare System (US)
Columbia University (US)
New Mexico VA Health Care System (US)
National Institute of Allergy and Infectious Diseases (US)
VA San Diego Healthcare System (US)
VA Ann Arbor Healthcare System (US)
Edward Hines, Jr. VA Hospital (US)
VA Puget Sound Health Care System (US)
University of Rochester Medicine (US)
Vanderbilt University Medical Center (US)
Baltimore VA Medical Center (US)
VA Palo Alto Health Care System (US)
Baylor College of Medicine (US)
The University of Texas at San Antonio Health Science Center (US)
Northport VA Medical Center (US)
James A. Haley Veterans' Hospital (US)
Lexington VA Health Care System (US)
University of California, Los Angeles (US)
ORCID: Levin, M.J.
Johnson, G.R.
Schmader, K.E.
Arbeit, R.D.
Simberkoff, M.S.
Gershon, A.A.
Weinberg, A.
Williams, H.M.
Peduzzi, P.N.
Neuzil, K.M.
Wright, P.F.
Griffin, M.R.
Marques, A.R.
Cotton, D.J.
Holodniy, M.
Toney, J.F.
Greenberg, R.N.
Hayward, A.R.
Irwin, M.R.
Kyriakides, T.C.
Chan, C.Y.
Annunziato, P.W.
Silber, J.L.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2005-06-02
Volume: 352
Issue: 22
Pages: 2271-2284
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa051016
OpenAlex: W2131041950
Cited by: 2,412
References: 40
Citations by year: 2026: 51 · 2025: 90 · 2024: 63 · 2023: 92 · 2022: 60 · 2021: 95 · 2020: 97 · 2019: 111 · 2018: 145 · 2017: 155 · 2016: 158 · 2015: 133 · 2014: 126 · 2013: 149 · 2012: 110
FWCI: 89.86
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: U.S. Department of Veterans Affairs
Office of Research and Development
Topics: Health Sciences › Medicine › Infectious Diseases › Herpesvirus Infections and Treatments
Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
Keywords: herpes zoster, postherpetic neuralgia, varicella-zoster virus, live attenuated zoster vaccine, older adults, vaccine efficacy, disease burden, cell-mediated immunity, injection site reactions
MeSH terms: Aged, Double-Blind Method, Female, Follow-Up Studies, Herpes Zoster, Humans, Immunologic Memory, Male, Middle Aged, Neuralgia, Vaccines, Attenuated, Herpesvirus 3, Human, Virus Activation, Incidence, Cost of Illness, Chickenpox Vaccine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks